阴性夜间血红蛋白尿症,病理生理学,诊断和治疗
Jens Peter Panse1, Britta Höchsmann2, Jörg Schubert3
1Department of Hematology, Oncology, University RWTH Medical School, Aachen, Germany.
概括
终端补充抑制剂 (CI) 降低了阴性夜间血红蛋白尿 (PNH) 中的血管内血解. 靠近的CI解决了血管外血解,改善了贫血和生活质量,但需要更多的数据来进行一线治疗.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 透性夜间血红蛋白尿 (PNH) 涉及血管内血解 (IVH) 由于补充系统调节失调.
- IVH导致贫血,疲劳和血栓形成,严重影响患者的健康.
- 终端补充级联抑制剂通过阻断IVH改善了生存率.
研究的目的:
- 为了比较终端和近端补体抑制剂在治疗PNH中的疗效.
- 评估近接补体抑制剂在管理外血管血解 (EVH) 中的作用.
- 强调在一线PNH治疗中需要治疗算法.
主要方法:
- 对终端补剂抑制剂 (例如,eculizumab,ravulizumab) 的临床数据的审查.
- 对近位补充抑制剂 (例如,佩格塞塔科普兰,达尼科潘,伊普塔科潘) 的研究分析.
- 评估患者的结果,包括血红蛋白水平,绝对网细胞计数 (ARC) 和生活质量 (QoL).
主要成果:
- 终端CI有效降低IVH,并改善PNH患者的存活率.
- 靠近的CI可以使显著的EVH患者的血红蛋白和ARC正常化,从而增强QoL.
- 一些终末期CI患者仍然经历了相关的EVH,需要替代治疗.
结论:
- 靠近的CI为PNH患者提供了有价值的治疗选择,患者患有持续的EVH.
- 需要一种治疗算法来指导PNH的第一线治疗选择.
- 需要进一步的现实数据来证实近邻信贷机构的长期好处,特别是在一线设置中.
相关概念视频
Disorders of Erythrocytes
897
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
897
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
180
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
180
Disorders of Hemostasis
738
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
738
Pulmonary Hypertension: Classification and Pathogenesis
152
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
152
Hemodialysis II: Procedure and Complications
2
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
2
Blood Transfusion and Agglutination
10.7K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.7K


